NewSquare Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-115	Closed	-$3.9K	–	651
2023 Q2	$3.9K	Hold	115	–	–	﹤0.01%	450
2023 Q1	$4.14K	Hold	115	–	–	﹤0.01%	473
2022 Q4	$5.13K	Buy	+115	New	+$5.13K	﹤0.01%	368